GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 17/11/2011
PIL Avamys

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 02/02/2010 and displayed until 17/11/2011
Reasons for adding or updating:
  • Change to storage instructions
  • Change to side-effects
  • Change to Further Information section
  • Change to, or new, use for medicine
Updated on 19/06/2009 and displayed until 02/02/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 13/01/2009 and displayed until 19/06/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   fluticasone furoate